Cancer Global Summit-CGS 2026

Immunotherapy trials lead the way in cancer science, testing new and innovative therapies that utilize the immune system to recognize and kill tumor cells. The session "Immunotherapy Trials" addresses the design, conduct, and results of clinical trials that drive immunotherapeutic approaches forward.".

These trials examine numerous strategies, such as immune checkpoint inhibitors, CAR T-cell therapy, cancer vaccines, and adoptive cell transfer. Carefully examining safety, efficacy, dosing, and combination regimens, immunotherapy trials yield pivotal data for the incorporation of new therapies into clinical practice. Biomarker-guided studies identify patients who are most likely to benefit, refine treatment regimens, and reduce adverse effects.

The session discusses considerations in trial design, ethical and regulatory considerations, and cutting-edge innovations like adaptive trial designs and integration of real-world data. Information learned from early-phase trials informs the next steps and speeds up the development of next-generation immunotherapies. Interaction among research centers, drug companies, and clinical centers is crucial to the progress of knowledge and translation of findings into successful treatments.

Participants will learn about current research, new therapies, and best practices in immunotherapy trial conduct. This session highlights the importance of clinical trials in revolutionizing cancer therapy, advancing patient benefit, and pushing the boundaries of immune-based precision oncology.